Patent ID: 11957732
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G | IPC A  G

Claim 4:
5. The method of claim 1, wherein
the cathepsin B binding agent is valine-citrulline;
L is —HN(CH2)bCO—; subscript “b” is 3;
R1 is C16 branched alkyl;
each of R2, R3, or R4 is methyl;
the chemotherapy agent is doxorubicin, liposomal doxorubicin, cisplatin, carboplatin, paclitaxel, albumin-bound paclitaxel, or docetaxel; and
the radionuclide therapy agent is 186/188Re, 177Lu, 153Sm, 90Y, 201Pb, or 198Au.